Novamind is building the infrastructure required for a regulated psychedelics industry.
Exclusively operating in jurisdictions with established regulations for the use of psychedelics, Novamind is empowering the people, technology and research that will allow society to safely access psychedelic treatments in guided settings.
Since 2019, Novamind has invested in and acquired world-class psychedelics clinics, retreats and clinical research organizations.
Novamind is committed to a values-oriented approach to business. We will use our platform as a force for good, acknowledging and supporting the interests of our stakeholders.